Adma Biologics reported $137.67M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Adma Biologics USD 137.67M 27.94M Sep/2025
Alnylam Pharmaceuticals USD 964.77M 397.66M Sep/2025
Dynavax Technologies USD 73.34M 16.79M Jun/2025
Takeda JPY 757.92B 55.68B Dec/2025